MX2009004776A - Celulas madre mesenquimaticas derivadas de medula osea como una fuente de progenitores neurales. - Google Patents
Celulas madre mesenquimaticas derivadas de medula osea como una fuente de progenitores neurales.Info
- Publication number
- MX2009004776A MX2009004776A MX2009004776A MX2009004776A MX2009004776A MX 2009004776 A MX2009004776 A MX 2009004776A MX 2009004776 A MX2009004776 A MX 2009004776A MX 2009004776 A MX2009004776 A MX 2009004776A MX 2009004776 A MX2009004776 A MX 2009004776A
- Authority
- MX
- Mexico
- Prior art keywords
- mesenchymal stem
- source
- stem cells
- bone marrow
- derived mesenchymal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0622—Glial cells, e.g. astrocytes, oligodendrocytes; Schwann cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0619—Neurons
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0623—Stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/13—Nerve growth factor [NGF]; Brain-derived neurotrophic factor [BDNF]; Cilliary neurotrophic factor [CNTF]; Glial-derived neurotrophic factor [GDNF]; Neurotrophins [NT]; Neuregulins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/08—Coculture with; Conditioned medium produced by cells of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
- C12N2506/1346—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells
- C12N2506/1353—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells from bone marrow mesenchymal stem cells (BM-MSC)
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Ophthalmology & Optometry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Se proveen métodos para tratar y/o reducir la severidad de esclerosis múltiple en un humano, administrando precursores neurales derivados de células madre mesenquimáticas autólogas; se describe también un método in vitro para la diferenciación de tipos de células neuronales y oligodendrogliales de precursores neurales derivados de células madre mesenquimáticas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US85651506P | 2006-11-03 | 2006-11-03 | |
PCT/US2007/023184 WO2008057443A2 (en) | 2006-11-03 | 2007-11-02 | Bone marrow-derived mesenchymal stem cells as a source of neural progenitors |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009004776A true MX2009004776A (es) | 2009-07-14 |
Family
ID=39365076
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009004776A MX2009004776A (es) | 2006-11-03 | 2007-11-02 | Celulas madre mesenquimaticas derivadas de medula osea como una fuente de progenitores neurales. |
Country Status (15)
Country | Link |
---|---|
US (5) | US8642331B2 (es) |
EP (2) | EP3031326A3 (es) |
CA (1) | CA2668200C (es) |
CY (1) | CY1120115T1 (es) |
DK (1) | DK2086332T3 (es) |
ES (1) | ES2663875T3 (es) |
HR (1) | HRP20180533T1 (es) |
HU (1) | HUE036745T2 (es) |
LT (1) | LT2086332T (es) |
MX (1) | MX2009004776A (es) |
PL (1) | PL2086332T3 (es) |
PT (1) | PT2086332T (es) |
RS (1) | RS57083B1 (es) |
SI (1) | SI2086332T1 (es) |
WO (1) | WO2008057443A2 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2086332T3 (en) | 2006-11-03 | 2018-04-16 | Multiple Sclerosis Res Center Of New York | Bone marrow derived mesenchymal stem cells as a source of neural progenitors |
US9301975B2 (en) * | 2009-05-01 | 2016-04-05 | Biocardia, Inc. | Method of preparing autologous cells and method of use for therapy |
US20120020931A1 (en) | 2010-06-02 | 2012-01-26 | Rutgers, The State University Of New Jersey | Therapeutic encapsulated embryonic stem cells and mesenchymal stromal cells |
MX368272B (es) | 2010-08-18 | 2019-09-26 | Deisher Theresa | Composiciones y métodos para inhibir la unión de células madre y células progenitoras a tejido linfoide y para regenerar centros germinales en tejidos linfáticos. |
US20120087868A1 (en) | 2010-10-08 | 2012-04-12 | Gabriele Todd | Nanoparticle-loaded cells |
WO2012070964A1 (ru) * | 2010-11-22 | 2012-05-31 | Farber Boris Slavinovich | Модифицированные олигопептиды с противораковыми свойствами и способ их получения |
EP3354725B1 (en) * | 2013-10-14 | 2019-12-04 | Hadasit Medical Research Services and Development Ltd. | Terminally differentiated neuronal lineages and uses thereof |
WO2015143074A1 (en) * | 2014-03-20 | 2015-09-24 | University Of Southern California | Brain cancer immunotherapy |
WO2016168993A1 (en) | 2015-04-22 | 2016-10-27 | Innolife Co., Ltd. | Methods of tissue repair and regeneration |
JP2018517743A (ja) * | 2015-06-15 | 2018-07-05 | メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ | 多系統萎縮症を治療するための自家間葉系幹細胞の使用 |
US20180369287A1 (en) | 2015-10-08 | 2018-12-27 | Neurona Therapeutics Inc. | Neural precursor cell populations and uses thereof |
WO2018211498A1 (en) | 2017-05-15 | 2018-11-22 | Stem Cell Medicine Ltd. | Treatment of multiple sclerosis with adipose-derived stem cells |
CN110709091A (zh) | 2017-05-15 | 2020-01-17 | 干细胞医药有限公司 | 使用长效格拉替雷和脂肪源性干细胞治疗多发性硬化症 |
WO2021020666A1 (en) * | 2019-07-26 | 2021-02-04 | Brexogen Inc. | Precursor cells of induced pluripotent stem cell-derived mesenchymal stem cells and method for preparing the same |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7037719B1 (en) | 1999-02-12 | 2006-05-02 | Stemcells California, Inc. | Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations |
US8017112B2 (en) * | 1999-05-14 | 2011-09-13 | Henry Ford Health System | Transplantation of bone marrow stromal cells for treatment of neurodegenerative diseases |
US20040208858A1 (en) | 2000-04-12 | 2004-10-21 | Gihan Tennekoon | Therapeutic uses for mesenchymal stromal cells |
US20040259254A1 (en) * | 2001-10-30 | 2004-12-23 | Osamu Honmou | Method for inducing differentiation mesodermal stem cells, es cells or immortalized cells into nervous system cells |
WO2006134602A2 (en) * | 2005-06-16 | 2006-12-21 | Ramot At Tel Aviv University Ltd. | Isolated cells and populations comprising same for the treatment of cns diseases |
DK2086332T3 (en) | 2006-11-03 | 2018-04-16 | Multiple Sclerosis Res Center Of New York | Bone marrow derived mesenchymal stem cells as a source of neural progenitors |
-
2007
- 2007-11-02 DK DK07867349.8T patent/DK2086332T3/en active
- 2007-11-02 SI SI200732020T patent/SI2086332T1/en unknown
- 2007-11-02 MX MX2009004776A patent/MX2009004776A/es active IP Right Grant
- 2007-11-02 ES ES07867349.8T patent/ES2663875T3/es active Active
- 2007-11-02 EP EP15195728.9A patent/EP3031326A3/en not_active Withdrawn
- 2007-11-02 HU HUE07867349A patent/HUE036745T2/hu unknown
- 2007-11-02 CA CA2668200A patent/CA2668200C/en not_active Expired - Fee Related
- 2007-11-02 RS RS20180406A patent/RS57083B1/sr unknown
- 2007-11-02 US US12/377,900 patent/US8642331B2/en active Active
- 2007-11-02 PL PL07867349T patent/PL2086332T3/pl unknown
- 2007-11-02 PT PT78673498T patent/PT2086332T/pt unknown
- 2007-11-02 LT LTEP07867349.8T patent/LT2086332T/lt unknown
- 2007-11-02 WO PCT/US2007/023184 patent/WO2008057443A2/en active Application Filing
- 2007-11-02 EP EP07867349.8A patent/EP2086332B1/en active Active
-
2011
- 2011-06-09 US US13/156,776 patent/US20110236357A1/en not_active Abandoned
-
2013
- 2013-12-23 US US14/139,152 patent/US9328329B2/en active Active
-
2014
- 2014-10-28 US US14/525,919 patent/US9657268B2/en active Active
- 2014-10-28 US US14/525,903 patent/US20150118198A1/en not_active Abandoned
-
2018
- 2018-03-30 HR HRP20180533TT patent/HRP20180533T1/hr unknown
- 2018-04-04 CY CY20181100378T patent/CY1120115T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
PL2086332T3 (pl) | 2018-07-31 |
US20150064145A1 (en) | 2015-03-05 |
EP3031326A3 (en) | 2016-09-14 |
DK2086332T3 (en) | 2018-04-16 |
HUE036745T2 (hu) | 2018-07-30 |
US20140308745A1 (en) | 2014-10-16 |
SI2086332T1 (en) | 2018-06-29 |
PT2086332T (pt) | 2018-04-04 |
RS57083B1 (sr) | 2018-06-29 |
LT2086332T (lt) | 2018-04-25 |
EP3031326A2 (en) | 2016-06-15 |
WO2008057443A9 (en) | 2008-07-17 |
US20100166712A1 (en) | 2010-07-01 |
WO2008057443A2 (en) | 2008-05-15 |
ES2663875T3 (es) | 2018-04-17 |
CY1120115T1 (el) | 2018-12-12 |
EP2086332A2 (en) | 2009-08-12 |
CA2668200C (en) | 2017-04-18 |
US9657268B2 (en) | 2017-05-23 |
EP2086332B1 (en) | 2018-01-10 |
EP2086332A4 (en) | 2010-08-11 |
US20110236357A1 (en) | 2011-09-29 |
HRP20180533T1 (hr) | 2018-05-18 |
US8642331B2 (en) | 2014-02-04 |
WO2008057443A3 (en) | 2008-11-20 |
US9328329B2 (en) | 2016-05-03 |
CA2668200A1 (en) | 2008-05-15 |
US20150118198A1 (en) | 2015-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009004776A (es) | Celulas madre mesenquimaticas derivadas de medula osea como una fuente de progenitores neurales. | |
MX2009004238A (es) | Metodos y composiciones para tratamiento de defectos oseos con poblaciones de celulas de placenta. | |
AU2017254264A1 (en) | Method for producing retinal tissue | |
MX2008001709A (es) | Produccion de celulas reprogramadas con potencial restablecido. | |
MX353245B (es) | Metodos para reprogramar células y sus usos. | |
WO2007100692A3 (en) | Method of generating human retinal progenitors from embryonic stem cells | |
SG170068A1 (en) | Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production | |
MX2012007414A (es) | Diferenciacion de celulas madres embrionarias humanas. | |
PL2447357T3 (pl) | Sposoby wytwarzania mikromieszków włosowych i brodawek de novo i stosowanie ich w badaniach in vitro i przeszczepach in vivo | |
SG169324A1 (en) | Differentiation of non-embryonic stem cells to cells having a pancreatic phenotype | |
WO2007136936A3 (en) | Dermis-derived cells for tissue engineering applications | |
MX343786B (es) | Diferenciacion de celulas madre embrionarias humanas. | |
WO2003004605A3 (en) | Mesenchymal cells and osteoblasts from human embryonic stem cell | |
GB2441718A (en) | Differentiation of primate pluripotent stem cells to cardiomyocyte-lineage cells | |
WO2007080590A3 (en) | Human embryonic stem cell-derived connective tissue progenitors for tissue engineering | |
EP2048227A3 (en) | Methods for proliferating stem cells | |
GB2485112A (en) | Differentiation of human embryonic stem cells | |
MX2009007391A (es) | Metodos para aumentar e inmovilizar células madre hematopoyéticas. | |
WO2010065551A3 (en) | Differentiation of stem cells with nanoparticles | |
GB2453074A (en) | Differentiation of primate pluripotent cells to hepatocyte-lineage cells | |
WO2009155041A3 (en) | Method to modulate hematopoietic stem cell growth | |
WO2011097242A3 (en) | Methods of isolating and culturing mesenchymal stem cells | |
WO2011068792A3 (en) | Compositions and methods for making and using bone marrow mesenchymal stem cells and erythroid progenitor cells | |
WO2008070258A3 (en) | Directed differentiation of human embryonic stem cells into mesenchymal/stromal cells | |
WO2009151301A3 (ko) | 인간배아줄기세포 유래 혈관전구세포를 이용한 창상 치료용 이식재 및 치료 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |